about
Vitamin C: update on physiology and pharmacologyDeterminants of Glycosaminoglycan (GAG) StructureGlycocalyx and its involvement in clinical pathophysiologiesThe amyloid precursor protein (APP) of Alzheimer disease and its paralog, APLP2, modulate the Cu/Zn-Nitric Oxide-catalyzed degradation of glypican-1 heparan sulfate in vivo.ScFv antibody-induced translocation of cell-surface heparan sulfate proteoglycan to endocytic vesicles: evidence for heparan sulfate epitope specificity and role of both syndecan and glypican.Screening for anticoagulant heparan sulfate octasaccharides and fine structure characterization using tandem mass spectrometryHeparan sulfate containing unsubstituted glucosamine residues: biosynthesis and heparanase-inhibitory activity.Tumorigenic and adhesive properties of heparanase.Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis.Heparan sulfate proteoglycans and human breast cancer epithelial cell tumorigenicity.Suppression of amyloid beta A11 antibody immunoreactivity by vitamin C: possible role of heparan sulfate oligosaccharides derived from glypican-1 by ascorbate-induced, nitric oxide (NO)-catalyzed degradation.Mechanosensing at the vascular interface.Significance of heparanase in cancer and inflammation.Hemodynamic shear stress characteristic of atherosclerosis-resistant regions promotes glycocalyx formation in cultured endothelial cellsThe endothelial glycocalyx: composition, functions, and visualization.Impact of heparanase and the tumor microenvironment on cancer metastasis and angiogenesis: basic aspects and clinical applicationsDifferential expression of syndecans and glypicans in chronically inflamed synovium.Fine-tuning of cell signaling by glypicans.Organ-specific heparan sulfate structural phenotypes.Internalization and trafficking of cell surface proteoglycans and proteoglycan-binding ligands.LARGE2-dependent glycosylation confers laminin-binding ability on proteoglycans.Heparan sulfate proteoglycans: structure, protein interactions and cell signaling.Shear-induced endothelial NOS activation and remodeling via heparan sulfate, glypican-1, and syndecan-1.Heparan sulfate biosynthesis: regulation and variability.Swarm chondrosarcoma: a continued resource for chondroblastic-like extracellular matrix and chondrosarcoma biology research.Implications of recent accumulating knowledge about endothelial glycocalyx on anesthetic management.Heparan sulfate degradation products can associate with oxidized proteins and proteasomes.The maternal plasma proteome changes as a function of gestational age in normal pregnancy: a longitudinal study.Suppression of glypican-1 autodegradation by NO-deprivation correlates with nuclear accumulation of amyloid beta in normal fibroblasts.RETRACTED: Glypican 1 stimulates S phase entry and DNA replication in human glioma cells and normal astrocytes.Copper-dependent co-internalization of the prion protein and glypican-1.Interaction of the amyloid precursor protein-like protein 1 (APLP1) E2 domain with heparan sulfate involves two distinct binding modes.Oxidation of heparan sulphate by hypochlorite: role of N-chloro derivatives and dichloramine-dependent fragmentation.MicroRNA-24 suppression of N-deacetylase/N-sulfotransferase-1 (NDST1) reduces endothelial cell responsiveness to vascular endothelial growth factor A (VEGFA).Age-related changes of plasma glycosaminoglycans.Transvascular protein transport in mice lacking endothelial caveolae.Mechanotransduction of the endothelial glycocalyx mediates nitric oxide production through activation of TRP channels.Hypoxia induces NO-dependent release of heparan sulfate in fibroblasts from the Alzheimer mouse Tg2576 by activation of nitrite reduction.
P2860
Q24654791-19ABC702-6238-4213-86B1-4AA694B5BB9DQ26797302-BC92972C-D41E-4B2E-8EE3-29FDD3D5887CQ28073125-4FD8FBE9-171B-4D96-BE3C-4F08AA01ECF9Q31144439-319C43C0-4E24-411C-88E2-24044BAC6335Q33506936-8224B47E-B6B7-409A-AC01-85EC8494A75CQ33546538-2D95BC62-8FB4-4E16-82CC-D140771DAC92Q34075861-6E8F0EC9-CCE9-465C-9A17-F185DB647DF4Q34137792-C449120E-06BD-436A-A3C3-02FEEEA1C7D6Q34398151-9BB91EC3-3C40-4897-BC4A-A3123D6E8A36Q34475894-FE5176FE-8767-4AC1-A1F9-98A5E04AEFBFQ35144959-411BC425-255F-4904-97D5-CFC68EB92A33Q35670148-65B24916-AD95-45D1-8E6D-EDD48A46796BQ36101233-DA743068-1894-4508-806E-BA1C72FD7D5AQ36538831-376A7A85-7981-45E7-B46A-8C418AFB0BDBQ36719459-B862744F-B636-45A3-80F5-70562AE22C4FQ36919158-D1FA3248-FF96-4558-9C98-CCF182D7538AQ36927550-B14FC112-395F-4BF1-9435-F48371AD6709Q37035025-E678BCBF-5E36-4843-937C-71A10CFBDB13Q37169432-54E8993B-CBFF-4FAE-8DAD-FA62E682527BQ37275287-507D9518-FE52-4950-862C-8E9432B95D8EQ37472546-6BF9D62B-BB3C-4989-88AE-F3CFD6FD726BQ37590177-510A3BDB-5CE9-4FA7-B535-76ACF8E94359Q37718732-73C92E9F-65A8-4B19-85A4-D2C8E7A89B61Q38050077-92D99087-F2B7-4987-8998-1005FDA57BB0Q38113828-ABD4B487-0289-49FF-8507-C5F80F662436Q38235924-E7AE8AE2-EBBB-40EE-BDC1-134C7F3B0389Q38301219-2AC32596-6490-475E-96C5-379EF5ABBC28Q38436237-D3EBA677-90A2-4A98-B675-0C2C0EA4649AQ38839799-7F9E7530-BBD5-49BE-9FB9-A703A45E194DQ39098101-CD55ACDC-BD4A-4AFD-8511-F291EEA47741Q40241315-0542B101-D492-4244-A4D0-C63578911127Q41246141-82010DFB-29B8-4F74-A507-83FF35C496B8Q41836217-A68D63B8-713E-4183-86BC-B56A17F90CDBQ42587744-97350D4A-B6C7-4C8B-9DBD-47A9970CD2FEQ46853169-5748C930-2BB4-404C-B2D2-E2988C6959ABQ46963063-C2B1BFF9-CC06-41AA-8D0C-F8E27EBC6EA1Q48493569-2C4C2521-8D20-44C3-B38E-511F9496EBB5Q51553914-9AB2E4A3-FCFC-4B47-9F97-1CB64ACBE736
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Novel aspects of glypican glycobiology.
@ast
Novel aspects of glypican glycobiology.
@en
type
label
Novel aspects of glypican glycobiology.
@ast
Novel aspects of glypican glycobiology.
@en
prefLabel
Novel aspects of glypican glycobiology.
@ast
Novel aspects of glypican glycobiology.
@en
P2093
P1476
Novel aspects of glypican glycobiology
@en
P2093
P2888
P304
P356
10.1007/S00018-004-3445-0
P577
2004-05-01T00:00:00Z